|
Zimmer Biomet Holdings Inc (NYSE: ZBH) |
|
Zimmer Biomet Holdings Inc Balance Sheets Quarterly
ZBH
|
Select the Financial Report: |
Period: |
|
|
|
ZBH Balance Sheets
(Quarterly, GAAP in millions $) |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
|
ASSETS |
| Cash & cash equivalent |
1,384.50 |
525.50 |
569.00 |
420.10 |
393.00 |
| Cash, Cash Equivalents Other |
- |
- |
- |
- |
- |
| Cash
& Short-term Investments |
1,384.50 |
525.50 |
569.00 |
420.10 |
393.00 |
| Accounts receivable |
1,533.40 |
1,480.70 |
1,481.50 |
1,418.00 |
1,446.40 |
| Other Receivables |
- |
- |
- |
- |
- |
| Notes Receivable, Current |
- |
- |
- |
- |
- |
| Inventories |
2,244.20 |
2,235.30 |
2,368.70 |
2,369.90 |
2,388.20 |
| Other Current Assets |
- |
- |
- |
- |
0.10 |
| Prepaid Expense And Other Assets Current |
428.20 |
430.10 |
444.80 |
431.40 |
403.80 |
| Total Current Assets |
5,590.30 |
4,671.50 |
4,864.00 |
4,639.40 |
4,631.50 |
| Equipment/Property/Plant Net |
2,064.90 |
2,048.80 |
2,107.20 |
2,103.00 |
2,090.90 |
| Goodwill net |
8,988.60 |
8,951.10 |
8,912.30 |
8,824.50 |
8,791.50 |
| Intangible Assets |
4,468.00 |
4,598.40 |
4,665.30 |
4,707.40 |
4,734.10 |
| Long-term investments |
- |
- |
- |
- |
- |
| Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
| Financial Instruments |
- |
- |
- |
- |
- |
| Tax Assets, Noncurrent |
- |
- |
- |
- |
- |
| Other Assets, Noncurrent |
1,072.10 |
1,095.40 |
1,171.50 |
1,245.70 |
1,204.40 |
| Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
| Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
| Total Assets |
22,183.90 |
21,365.30 |
21,720.30 |
21,520.00 |
21,452.40 |
| LIABILITIES |
| Accounts Payable, Current AC |
301.30 |
194.60 |
322.40 |
341.80 |
370.30 |
| Employee-related Liabilities, Current AC |
- |
- |
- |
- |
- |
| Financial Instruments |
- |
- |
- |
- |
- |
| Long-term Debt, Current Maturities LO |
600.00 |
863.00 |
1,713.00 |
1,878.00 |
970.00 |
| Other Liabilities, Current |
1,393.60 |
1,393.30 |
1,535.90 |
1,388.60 |
1,386.40 |
| Accrued Income Taxes, Current TA |
- |
- |
- |
- |
70.30 |
| Deferred Liability and Revenue |
- |
- |
- |
- |
- |
| Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
| Contract With Customer Refund Liability Current |
- |
- |
- |
- |
- |
| Deferred Income Tax Liabilities Net |
- |
352.50 |
- |
- |
370.40 |
| Total Current Liabilities |
2,294.90 |
2,450.90 |
3,571.30 |
3,608.40 |
2,797.00 |
| Long-term debt |
6,576.30 |
5,341.60 |
4,737.70 |
3,956.70 |
4,826.20 |
| Capital Lease and Other |
- |
- |
- |
- |
- |
| Long-term Debt Convertible |
- |
- |
- |
- |
- |
| Total
Long-term Debt |
6,576.30 |
5,341.60 |
4,737.70 |
3,956.70 |
4,826.20 |
| Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
| Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
| Deferred credits, Noncurrent |
- |
- |
- |
- |
- |
| Accrued Income Taxes, Noncurrent AC1 |
- |
- |
- |
- |
275.80 |
| Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
| Other liabilities, Noncurrent |
908.80 |
1,096.60 |
1,028.10 |
1,205.50 |
947.40 |
| Total Liabilities |
9,780.00 |
8,889.10 |
9,337.10 |
8,770.60 |
8,846.40 |
SHAREHOLDER'S EQUITY |
| Common Stock Value |
3.20 |
3.20 |
3.20 |
3.20 |
3.20 |
| Treasury Stock Value |
-8,637.10 |
-8,405.70 |
-8,347.50 |
-7,744.30 |
-7,648.90 |
| Additional Paid In Capital Common Stock |
10,086.60 |
10,038.10 |
10,017.50 |
9,974.90 |
9,945.90 |
| Retained Earnings / Accumulated Deficit |
11,229.70 |
11,095.30 |
10,903.70 |
10,702.50 |
10,509.00 |
| Other Equity |
-287.30 |
-262.80 |
-202.20 |
-195.30 |
-211.30 |
| Noncontrolling interests & other |
8.70 |
8.10 |
8.50 |
8.40 |
8.10 |
| Total
Stockholder's Equity |
12,403.80 |
12,476.20 |
12,383.20 |
12,749.40 |
12,606.00 |
| Liabilities & Stockholder's
Equity |
22,183.90 |
21,365.30 |
21,720.30 |
21,520.00 |
21,452.40 |
|
